Search Results

Mar 17, 2026, 09:30 ET PWL Capital Selects d1g1t as its WealthTech Partner to Accelerate Growth and Elevate Client Experiences

of Ontario (FSRA) and in Quebec by the Autorité des marchés financiers (AMF). PWL Advisors Inc. is not a member of CIPF.About d1g1t d1g1t is a leading wealth management technology provider that helps RIAs, Multi-family offices, Broker Dealers, Custodians, and Bank Advisor Networks

More news about: D1g1t Inc.

Mar 17, 2026, 09:28 ET Mrs. T's® Introduces Snack Pierogies, Your Family's New Snacktime Sidekick

Later that year, Ted sold the very first pierogy samples to his local grocery store in Shenandoah, PA, and to honor his mother Mary Twardzik – the Mrs. T – he called his company Mrs. T's® Pierogies. Now, more than 70 years later, Mrs. T's® Pierogies is the largest producer of frozen pierogies, producing

More news about: Mrs. T's Pierogies

Mar 17, 2026, 09:25 ET RaySecur Advances $1.5M NSF-Funded AI Program for Terahertz Threat Detection with Launch of Digital Platform

RaySecur, the leader in real-time 4D T-ray (terahertz) security detection systems, today announced progress in a $1.5 million National Science Foundation (NSF) development program to create

More news about: RaySecur Inc.

Mar 17, 2026, 09:00 ET Körber accelerates AI innovation in logistics and supply chain in collaboration with NVIDIA

www.koerber.comMedia contact:Domenico MenduniHead of Marketing & Communications Körber Business Area Supply Chain T +39 366.5692253 [email protected]

More news about: Körber

Mar 17, 2026, 08:58 ET Sequential™ desarrollará una plataforma de descubrimiento impulsada por IA para pruebas multiómicas

cuenta con laboratorios en Cambridge, Nueva York y Singapur. Galardonada con el título de "Solución de Pruebas Más Significativa" de la Industria (C&T, 2022). Hasta la fecha, Sequential ha recopilado más de 50.000 muestras de microbioma cutáneo humano y sus correspondientes formulaciones, probadas

More news about: Sequential

Mar 17, 2026, 08:41 ET Y+X Entertainment Unveils LumiView, a Premium Vertical IP Platform Set for August Launch

MJ Global Communications [email protected] | T: +1-646-225-6590

More news about: Y+X Entertainment

Mar 17, 2026, 08:30 ET A2GOLD IDENTIFIES DISTRICT SCALE ANTIMONY POTENTIAL AT THE TAYLOR SILVER-GOLD PROJECT IN NEVADA

anomalous gold defined by surface and soil samplingChannel samples returning up to 4.2 g/t gold over 11 metres, including 7.1 g/t gold over 3.3 metresDrill intercept from SPT-66 including 1.02 g/t gold over 18.3 metres starting at surfaceGeological observations suggest the antimony

More news about: A2 Gold Corp

Mar 17, 2026, 08:00 ET WellSaid Closes Venture Debt Round with Multiplier Capital

customer-facing applications. The company enters this round with high gross margins, a strong and growing enterprise customer base that includes Microsoft, T-Mobile, Progressive, Humana, and ServiceNow, and patent-protected intellectual property in AI voice generation."This round is about more than capital,"

More news about: WellSaid Labs, Inc.

Mar 17, 2026, 07:51 ET /C O R R E C T I O N -- Ignite Enterprise Software Solutions, Inc./

More news about: Ignite Enterprise Software Solutions, Inc.

Mar 17, 2026, 07:45 ET Achieve cuts personal loan APRs to 6.25%

first personal loan programs to use FICO® Score 10 T, which uses trended credit data for more informed lending decisions and lower expected delinquencies, without affecting approval rates. To better serve

More news about: Achieve

Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia submissão regulatória suplementar de MINJUVI® (tafasitamabe) para linfoma folicular na Argentina e no México

T: 514.484.4483T. +598.2626.2344

More news about: Knight Therapeutics Inc.

Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la presentación regulatoria complementaria de MINJUVI® (tafasitamab) para linfoma folicular en Argentina y México

T: 514-484-4483T: +598-2626-2344

More news about: Knight Therapeutics Inc.

Mar 17, 2026, 07:35 ET Knight Therapeutics Anuncia Aprovação de Indicação Adicional para MINJUVI® (tafasitamabe) no Brasil

T: 514.484.4483T. +598.2626.2344

More news about: Knight Therapeutics Inc.

Mar 17, 2026, 07:35 ET Knight Therapeutics anuncia la aprobación de una indicación adicional para MINJUVI® (tafasitamab) en Brasil

T: 514-484-4483T: +598-2626-2344

More news about: Knight Therapeutics Inc.

Mar 17, 2026, 07:00 ET AppZen completes Workday Integration for AI-powered Expense Audit

Anant Kale, CEO and co-founder of AppZen, "including stronger policy and regulatory compliance, meaningful reductions in T&E spend, and a better employee experience through faster reimbursements. As Workday continues to expand its role at the center of modern finance operations,

More news about: AppZen

Mar 17, 2026, 07:00 ET New Research Finds Luxury Travel Demand Expanding Beyond the Ultra-Wealthy

rewards and member benefits. The company's Travel Privileges program opens up the world of travel for companies like American Express, T-Mobile, Alaska Air, USAA and Marriott Vacation Club by offering their customers more value through exclusive pricing and encouraging discovery with relevant

More news about: Arrivia

Mar 17, 2026, 06:09 ET /C O R R E C T I O N -- Seger Surgical Solutions/

More news about: Seger Surgical Solutions

Mar 17, 2026, 06:00 ET Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients

Singapore-backed company, with labs in Cambridge, New York City and Singapore. Awarded the title "Most Significant" Testing Solution in the Industry - (C&T, 2022). To date, Sequential has amassed over 50,000 human skin microbiome samples and corresponding formulations tested in vivo on the skin. With this

More news about: Sequential

Mar 17, 2026, 03:00 ET Candid launches Live Marketing: "AI will perform 90 per cent of all operational marketing tasks".

photographs of Gérard Ghazarian (Founder) and Rudiger Wanck (CEO). https://we.tl/t-EU1OtoXCDWPhoto - https://mma.prnewswire.com/media/2934990/Candid.jpg

More news about: Candid